Dr. David Diemert attends the Joint Coordinating Board meeting of TDR (Special Programme for Research and Training in Tropical Diseases)

Featured News
Dr. Diemert and colleague smiling in front of the TDR step and repeat banner
Dr. Diemert with colleagues and WHO Director General Dr.Ghebreyesus

This year marks the 50th anniversary of the Special Programme for Research and Training in Tropical Diseases (TDR). This is a global programme of scientific collaboration that helps facilitate, support and influence efforts to combat diseases of poverty co-sponsored by the United Nations Children’s Fund (UNICEF), the United Nations Development Programme (UNDP), the World Bank and the World Health Organization (WHO).  

VRU Director, Dr. David Diemert, was in Geneva, Switzerland where he met with Director-General Tedros Adhanom Ghebreyesus and other leaders in the field of tropical disease research to discuss a range of topics including his work on the hookworm vaccine.

Tropical Diseases

Latest News

Picture of small pox with the outer and inner core
Results show safety and immunogenicity of fractional doses of the MVA-BN mpox vaccine
This was a phase 2, randomized, open-label, non-placebo controlled trial to evaluate two partial doses o the Modified Vaccinia Ankara-Bavarian Nordin (MVA-BN) vaccine for protection against mpox.
Lassa Virus under a microscope
Safety and Immunogenicity of an rVSV Lassa Fever Vaccine Candidate
This was a phase 1, double-blind trial to examine the safety and immunogenicity of a replication-competent recombinant vesicular stomatitis virus-vectored vaccine to reduce the risk of infection and severe illness from Lassa Fever.
An omicron COVID virus. A gray virus with red and orange projections.
The effect of Omicron BA.1-based booster mRNA vaccination on the incidence of COVID-19
The GW VRU is pleased to share the findings from a Phase 2 clinical trial that evaluated the effects of omicron-based COVID-19 vaccines in providing an increased level of protection against COVID-19 infection. This study adds to the evidence that matching COVID-19 vaccines to the circulating…